Federal contract award
75N93022C00009
THE CONTRACTOR SHALL PROVIDE COMPREHENSIVE QUALITY ASSESSMENT PROGRAMS TO CLINICAL PHARMACOLOGY LABORATORIES (LABS) THAT TEST SAMPLES FROM SUBJECTS ENROLLED IN NIAID SUPPORTED CLINICAL STUDIES. OPTIONS TO PROVIDE INCREASED LEVEL OF EFFORT TO SUPPORT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $10.0M |
| Current contract value | $10.0M |
| Potential contract value / ceiling | $17.6M |
| Start date | May 30, 2022 |
| Current end date | May 29, 2027 |
| Potential end date | May 29, 2029 |
| Latest award activity | May 26, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 26, 2026 | P00009 | $1.9M | CLINICAL PHARMACOLOGY QUALITY ASSURANCE (CPQA) |
| May 28, 2025 | P00008 | $1.8M | CLINICAL PHARMACOLOGY QUALITY ASSURANCE (CPQA) |
| Aug 8, 2024 | P00007 | $107.5K | CLINICAL PHARMACOLOGY QUALITY ASSURANCE (CPQA) |
| Jul 29, 2024 | P00006 | $114.5K | CLINICAL PHARMACOLOGY QUALITY ASSURANCE (CPQA) |
| May 22, 2024 | P00005 | $1.8M | CLINICAL PHARMACOLOGY QUALITY ASSURANCE (CPQA) |
| Jun 27, 2023 | P00004 | $0 | CLINICAL PHARMACOLOGY QUALITY ASSURANCE (CPQA) |
| May 25, 2023 | P00003 | $2.3M | CLINICAL PHARMACOLOGY QUALITY ASSURANCE (CPQA) |
| Jan 6, 2023 | P00002 | $0 | CLINICAL PHARMACOLOGY QUALITY ASSURANCE (CPQA) |
| Aug 9, 2022 | P00001 | $226.2K | THE CONTRACTOR SHALL PROVIDE COMPREHENSIVE QUALITY ASSESSMENT PROGRAMS TO CLINICAL PHARMACOLOGY LABORATORIES (LABS) THAT TEST SAMPLES FROM SUBJECTS ENROLLED IN NIAID SUPPORTED CLINICAL STUDIES. OPTIONS TO PROVIDE INCREASED LEVEL OF EFFORT TO SUPPORT |
| May 19, 2022 | 0 | $1.7M | THE CONTRACTOR SHALL PROVIDE COMPREHENSIVE QUALITY ASSESSMENT PROGRAMS TO CLINICAL PHARMACOLOGY LABORATORIES (LABS) THAT TEST SAMPLES FROM SUBJECTS ENROLLED IN NIAID SUPPORTED CLINICAL STUDIES. OPTIONS TO PROVIDE INCREASED LEVEL OF EFFORT TO SUPPORT |
Estimated positioning window
May 29, 2028 – Nov 29, 2028
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2029-05-29 (940 days from calculation)
- +15 points
- 67 historical awards in this buyer and category group
- +15 points
- 10 recorded award transactions
- +10 points
- Latest award action: 2026-05-26
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Shane Sarchiapone | Contact | shane.sarchiapone@nih.gov 301-761-7504 | Source | Jun 1, 2022 |
| John Manouelian | Contact | manouelj@niaid.nih.gov 240-669-5152 | Source | Jun 1, 2022 |
| Shane Sarchiapone | Contact | shane.sarchiapone@nih.gov 301-761-7504 | Source | Mar 2, 2021 |
| John Manouelian | Contact | manouelj@niaid.nih.gov 240-669-5152 | Source | Mar 2, 2021 |
| Shane Sarchiapone | Contact | shane.sarchiapone@nih.gov 301-761-7504 | Source | Dec 28, 2020 |
| John Manouelian | Contact | manouelj@niaid.nih.gov 240-669-5152 | Source | Dec 28, 2020 |
| Shane Sarchiapone | Contact | shane.sarchiapone@nih.gov 301-761-7504 | Source | Dec 11, 2020 |
| John Manouelian | Contact | manouelj@niaid.nih.gov 240-669-5152 | Source | Dec 11, 2020 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.